TALPHERA, INC. Segment Reporting Other Item Amount
TALPHERA, INC. (TLPH) reported Segment Reporting Other Item Amount of -$1.07 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-05-13
- TALPHERA, INC. segment reporting other item amount for the quarter ending 2026-03-31 was -$1.07M.
- TALPHERA, INC. segment reporting other item amount for the quarter ending 2025-12-31 was $558.00K.
- TALPHERA, INC. segment reporting other item amount for the quarter ending 2025-09-30 was $1.18M.
- TALPHERA, INC. segment reporting other item amount for the quarter ending 2025-06-30 was -$28.00K.
- TALPHERA, INC. segment reporting other item amount for fiscal 2025 was $1.68M.
- TALPHERA, INC. segment reporting other item amount for fiscal 2024 was -$969.00K.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$1.07M 10-Q · filed 2026-05-13 | -$516.00K derived: sum of 2 quarters · filed 2026-05-13 | $659.00K derived: sum of 3 quarters · filed 2026-05-13 | $631.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $558.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.73M derived: sum of 2 quarters · filed 2026-03-23 | $1.71M derived: sum of 3 quarters · filed 2026-03-23 | $1.68M 10-K · filed 2026-03-23 |
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-12 | $1.15M derived: sum of 2 quarters · filed 2025-11-12 | $1.12M 10-Q · filed 2025-11-12 | $252.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | -$28.00K 10-Q · filed 2025-08-14 | -$58.00K 10-Q · filed 2025-08-14 | -$923.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.07M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-03-31 | -$30.00K 10-Q · filed 2026-05-13 | -$895.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.04M derived: sum of 3 quarters · filed 2026-05-13 | -$1.17M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$1.01M derived: sum of 2 quarters · filed 2026-03-23 | -$1.14M derived: sum of 3 quarters · filed 2026-03-23 | -$969.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$148.00K 10-Q · filed 2025-11-12 | -$279.00K derived: sum of 2 quarters · filed 2025-11-12 | -$104.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$131.00K 10-Q · filed 2025-08-14 | $44.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |